Edesa Biotech (EDSA) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 13, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about EDSA filings

Are insiders buying or selling Edesa Biotech Inc (EDSA) stock?

Neither. Edesa Biotech Inc (EDSA) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded EDSA recently?

None. No member of Congress disclosed a EDSA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EDSA smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

6 funds hold a position.

Questions about EDSA filings

Are insiders buying or selling Edesa Biotech Inc (EDSA) stock?

Neither. Edesa Biotech Inc (EDSA) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded EDSA recently?

None. No member of Congress disclosed a EDSA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EDSA smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 7, 2026

Earnings came in 36.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 7, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.60-36.36% miss

-$0.44 expected

Revenue (FY)

$0.00

Year ended Sep 30, 2021 · SEC filing

Next report

Estimated report: Dec 11, 2026, in 28 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 7, 2026	-$0.60est. -$0.44	-36.36%miss	Not on file	Not on file
Mar 31, 2026Reported May 14, 2026	-$0.49est. -$0.26	-88.46%miss	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 13, 2026	-$0.28est. -$0.45	+37.78%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Dec 12, 2025	-$0.32est. -$0.56	+42.86%beat	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 8, 2025	-$0.25est. -$0.26	+3.85%beat	Not on file	Not on file
Mar 31, 2025Reported May 14, 2025	-$0.30est. -$0.29	-3.45%miss	Not on file	Not on file
Dec 31, 2024Reported Feb 14, 2025	-$0.48est. -$0.31	-54.84%miss	Not on file	Not on file
Sep 30, 2024Reported Dec 13, 2024	-$0.29est. -$0.54	+46.30%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $2.11
High: $2.32
Low: $1.85
Prev close: $2.02
52-wk high: $20.32
52-wk low: $0.72
Mkt cap: $30.0M
ROE: -122.9%
Fwd P/E: 0.2x
Beta: 1.24
P/S: 130462.3x
P/B: 48.5x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 0.18
Market cap: $30M

Valuation

P/S130462.29
P/B48.46

Quality

Operating margin0.0%
ROE-122.9%
ROA-66.4%

Growth

Beta1.24

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

37balanced

20D volatility

117%annualized

52-week range

$2.22

$0.72$20.32

20D support

$1.85recent floor

20D resistance

$3.93recent ceiling

Returns

5D +2.3%20D -16.2%60D -61.1%

Price vs moving averages

SMA20 -11.5%SMA50 -34.6%SMA200 -61.0%

Volume pace

107.66xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 7, 2026

-$0.60est. -$0.44

-36.36%

Not on file

Mar 31, 2026May 14, 2026

-$0.49est. -$0.26

-88.46%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Feb 13, 2026

-$0.28est. -$0.45

+37.78%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Dec 12, 2025

-$0.32est. -$0.56

+42.86%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2025Aug 8, 2025

-$0.25est. -$0.26

+3.85%

Not on file

Mar 31, 2025May 14, 2025

-$0.30est. -$0.29

-3.45%

Not on file

Dec 31, 2024Feb 14, 2025

-$0.48est. -$0.31

-54.84%

Not on file

Sep 30, 2024Dec 13, 2024

-$0.29est. -$0.54

+46.30%

Not on file

Edesa Biotech Inc

Smart money at a glance

What do analysts expect?

Questions about EDSA filings

Questions about EDSA filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 36.4% below what analysts expected.

Estimated report: Dec 11, 2026, in 28 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Edesa Biotech Inc

Smart money at a glance

What do analysts expect?

Questions about EDSA filings

Questions about EDSA filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 36.4% below what analysts expected.

Estimated report: Dec 11, 2026, in 28 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Edesa Biotech Inc

Overview

Questions about EDSA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Edesa Biotech Inc

Overview

Questions about EDSA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.